HEY, ABBOTT! YOUR ALLY GOES IT ALONE: TAKEDA'S U.S. DRIVE STARTS HERE.

Crain's Chicago Business, March, 1999 by SOMASUNDARAM, MEERA

Takeda Chemical Industries Ltd., Japan's largest drug company, is making an aggressive push into the U.S. market and using a new office here as its launching pad. Takeda Pharmaceuticals America Inc. (TPA), a newly created marketing unit of the Japanese parent, will launch major hiring, selling and marketing initiatives from its new U.S.

headquarters in Lincolnshire this month. The move will weaken ties between Takeda and longtime partner Abbott Laboratories. The companies 22 years ago formed a lucrative joint venture, TAP Holdings Inc., to develop and market new drugs. But the bonds began to loosen in 1997 when Takeda decided not to renew a contract giving North Chicago-based Abbott a right of first refusal to distribute Takeda's new drugs. ``For a long...

Read the rest of this article with a Free Trial at HighBeam Research.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works.